Topics

Trade, IP And Oncology Deals: What You Need To Know About China And JPM20

16:15 EST 15 Jan 2020 | SCRIP

China was a focus of discussions at the 2020 J.P. Morgan Healthcare Conference, as a Phase One trade agreement was...

      

Related Stories

 

Original Article: Trade, IP And Oncology Deals: What You Need To Know About China And JPM20

NEXT ARTICLE

More From BioPortfolio on "Trade, IP And Oncology Deals: What You Need To Know About China And JPM20"

Quick Search

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...